What is Convertible Note?

A convertible note is a short-term debt instrument commonly used in cannabis industry financing that converts into equity at a later date, typically during a future funding round. These hybrid securities have become increasingly popular among cannabis companies seeking to raise capital while navigating complex regulatory environments and banking restrictions. Convertible notes function as loans that automatically convert to company shares when specific triggers occur, most commonly during a qualified financing round (usually Series A or later). The conversion typically happens at a discount to the share price paid by new investors—commonly 15-25%—providing early investors with preferential terms for taking on higher risk. Key terms include the conversion discount, valuation cap (setting a maximum company valuation for conversion purposes), interest rate (usually 4-8% annually), and maturity date (typically 12-24 months). Some notes include a "most favored nation" clause, ensuring investors receive the best terms offered to other note holders. In the cannabis sector, convertible notes address several industry-specific challenges. Traditional bank lending remains limited due to federal prohibition, making alternative financing crucial. The instrument allows companies to raise capital quickly without establishing a precise valuation—particularly valuable in a rapidly evolving market where traditional valuation methods may not apply. According to Viridian Capital Advisors, convertible notes represented approximately 15-20% of cannabis financing deals in recent years, with amounts typically ranging from $500,000 to $5 million for smaller companies, though larger operators have raised $10-50 million through convertible structures. Risks include potential dilution for founders, the possibility of forced conversion at unfavorable terms, and the challenge of repaying principal if conversion doesn't occur. For investors, risks include potential total loss if the company fails before conversion and limited upside compared to direct equity investment. *This information is for educational purposes only and should not be considered investment advice. Cannabis investments carry significant risks and regulatory uncertainties.*